ClinicalTrials.govpublic full text
NAC to Prevent Cisplatin-induced Hearing Loss
neuroectodermal tumors, primitive, liver neoplasms, osteosarcoma, other childhood cancers using cisplatin-based regimens, cisplatin, n-acetylcysteine, hearing loss, otoprotection, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856438
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.